Bank of New York Mellon Corp Increases Stake in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Bank of New York Mellon Corp boosted its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 12.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 295,744 shares of the semiconductor company’s stock after purchasing an additional 33,854 shares during the quarter. Bank of New York Mellon Corp owned about 0.91% of Axcelis Technologies worth $42,052,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. GAMMA Investing LLC raised its holdings in shares of Axcelis Technologies by 109.4% in the 1st quarter. GAMMA Investing LLC now owns 266 shares of the semiconductor company’s stock worth $30,000 after purchasing an additional 139 shares during the period. Blue Trust Inc. increased its position in Axcelis Technologies by 223.8% during the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock worth $39,000 after purchasing an additional 188 shares in the last quarter. Assetmark Inc. raised its holdings in Axcelis Technologies by 690.0% in the fourth quarter. Assetmark Inc. now owns 474 shares of the semiconductor company’s stock valued at $61,000 after buying an additional 414 shares during the period. Kessler Investment Group LLC acquired a new position in Axcelis Technologies during the fourth quarter valued at approximately $77,000. Finally, Advisors Asset Management Inc. grew its stake in Axcelis Technologies by 17.5% during the first quarter. Advisors Asset Management Inc. now owns 670 shares of the semiconductor company’s stock worth $75,000 after buying an additional 100 shares during the period. Institutional investors and hedge funds own 89.98% of the company’s stock.

Insider Transactions at Axcelis Technologies

In related news, Director Jorge Titinger sold 6,086 shares of Axcelis Technologies stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $109.98, for a total value of $669,338.28. Following the completion of the transaction, the director now directly owns 5,891 shares in the company, valued at $647,892.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.43% of the company’s stock.

Wall Street Analyst Weigh In

ACLS has been the topic of a number of research reports. DA Davidson raised their target price on shares of Axcelis Technologies from $150.00 to $175.00 and gave the company a “buy” rating in a research note on Monday, July 15th. Bank of America boosted their price objective on Axcelis Technologies from $125.00 to $150.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 10th. Benchmark lowered their target price on Axcelis Technologies from $180.00 to $175.00 and set a “buy” rating for the company in a research note on Friday, August 2nd. Craig Hallum raised their target price on Axcelis Technologies from $130.00 to $174.00 and gave the company a “buy” rating in a report on Friday, July 12th. Finally, B. Riley decreased their price target on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating for the company in a report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Trading Down 0.1 %

Shares of ACLS opened at $109.33 on Monday. Axcelis Technologies, Inc. has a one year low of $93.77 and a one year high of $196.03. The stock has a 50-day moving average price of $125.96 and a 200 day moving average price of $117.63. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.26 and a current ratio of 4.42. The company has a market capitalization of $3.57 billion, a P/E ratio of 14.44, a P/E/G ratio of 3.30 and a beta of 1.61.

Axcelis Technologies (NASDAQ:ACLS) last released its earnings results on Wednesday, July 31st. The semiconductor company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.37 by $0.18. The company had revenue of $256.51 million during the quarter, compared to analysts’ expectations of $250.06 million. Axcelis Technologies had a return on equity of 27.35% and a net margin of 21.54%. The business’s revenue was down 6.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.86 EPS. Sell-side analysts forecast that Axcelis Technologies, Inc. will post 6.05 EPS for the current fiscal year.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.